July 23, 2001

4:00 pm-7:00 pm Registration
6:00 pm-7:00 pm Opening Reception (open bar and hors d'oeuvres)
7:00 pm-8:30 pm Dinner
Dinner Speaker:  Hugo W. Moser, MD,
Kennedy Krieger Institute and Johns Hopkins University
School of Medicine, Baltimore, Maryland
"Emerging Therapies for Neurologic Disorders"
(panelists do not attend the dinner)                                                                                                                                                                                                                                                                                                                                

Evening Session: Verbal Apraxia: Current Thoughts
Chair:  Marilyn Agin, MD

8:30 pm-8:40 pm Opening and Welcoming Remarks
  Marilyn Agin, MD and Ms. Lisa Geng
8:40 pm-9:10 pm "Verbal Apraxia: The Perspective of a Developmental Pediatrician"     
Marilyn Agin, MD
9:10 pm-9:40 pm  "Verbal Apraxia: The Perspective of a Speech Therapist"
  Nancy Kaufman, MA, CCC-SLP
9:40 p.m.-10:10 p.m. Discussion
All Panelists
10:10 pm.  Adjourn

July 24, 2001

7:00 am-8:00 am Registration

Morning Session: Essential Fatty Acids (EFAs) and the Brain
Chairs: Susan E. Carlson, Ph.D. and Robert Katz, Ph.D.

8:00 am-8:30 am Welcome and Introduction:  "What are EFAs?
   Susan E. Carlson, PhD and Robert Katz, PhD
* Each presentation includes a 5-minute Question and Answer period.

8:30 am-9:00 am "Psychiatric Consequences of Omega-3 Fatty Acid Insufficiency"
   Joseph Hibbeln, MD
9:00 am-9:30 am "Omega-3 Fatty Acids in Neuropsychological Disorders"
   Andrew L. Stoll, MD
9:30 am-9:50 am Coffee Break
9:50 am-10:20 am "EFA Supplementation Trials in Premature Babies and Infants"
   Susan E. Carlson, Ph.D.
10:20 am-10:50 am "Therapeutic Trials in Autism Spectrum Disorders"
   Andrew Zimmerman, MD
10:50 am-11:30 am "EFAs as Potential Therapeutic Agents in Verbal Apraxia:
Analysis of Professional Anecdotal Case Reports"
  Marilyn Agin, MD, Lori Roth, MA, CCC-SLP and Robert Katz,   PhD
11:30 am-12:15 am Roundtable Discussion:"Are Clinical Studies/Trials of EFA
Supplementation in Verbal Apraxia Timely and Justified?"
All Panel Members
12:15 am-1:00 pm Lunch

Afternoon Session: Verbal Apraxia; Possible Clinical Studies/Trials
Chairs: Andrew Zimmerman, MD and Andrew L. Stoll, MD

1:00 pm-1:10 pm "Clinical Tools for the Assessment of the Apraxic Child"
  Lori Roth, MA, CCC-SLP
1:10 pm-1:20 pm "Fatty Acid Profiles: Markers of EFA Status"
  Ann Moser
1:20 pm-1:30 pm "Neurobehavioral Markers"
  Andrew Zimmerman, MD
1:30 pm-1:40 pm "Neurophysiological Measures of Cognitive & Motorical
Development During Early Infancy"

  Jennifer Hill-Karrer, PhD
1:40 pm-2:40 pm "Designing EFA Supplementation Studies/Trials for Verbal Apraxia"
  All Panel Members
2:40 pm-3:00 pm Coffee Break

Closing Session: Summary and Recommendations
Chairs: Andrew Zimmerman, MD, and Lori Roth, MA, CCC-SLP

3:00 pm-3:30 pm Discussion of the Planned Clinical Research,
Formulation of Recommendations and Closing Remarks

All Panel Members
3:30 pm-  Adjourn
C.H.E.R.A.B. Foundation
Emergency Fact-Finding Workshop on

"Essential Fatty Acids and Verbal Apraxia:  A New Potential Therapeutic Intervention"
July 23-24, 2001, Headquarters Plaza Hotel, Morristown, New Jersey
Workshop Details
Other Speakers & Panelists